| (S)-nicotine | multiple interactions | EXP | | 6480464 | Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNK2 mRNA]; more ... | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNK2 mRNA]; more ... | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | increases expression | EXP | | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNK2 mRNA | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TNK2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1305957 | 6480464 | Ethinyl Estradiol results in decreased expression of TNK2 mRNA | CTD | PMID:17557909 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TNK2 mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:1305957 | 6480464 | 2,4-dinitrotoluene affects the expression of TNK2 mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:1305957 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of TNK2 mRNA] | CTD | PMID:17109745 |
| 2-methylcholine | affects expression | ISO | RGD:1346409 | 6480464 | beta-methylcholine affects the expression of TNK2 mRNA | CTD | PMID:21179406 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:1346409 | 6480464 | Methylcholanthrene promotes the reaction [AHR protein binds to TNK2 promoter] | CTD | PMID:20348232 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of TNK2 mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:1305957 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of TNK2 mRNA] | CTD | PMID:17109745 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of TNK2 mRNA | CTD | PMID:21715664 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:1305957 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of TNK2 mRNA] | CTD | PMID:17109745 |
| cadmium atom | decreases expression | ISO | RGD:1346409 | 6480464 | Cadmium results in decreased expression of TNK2 mRNA | CTD | PMID:21297354 |
| caffeine | multiple interactions | EXP | | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of TNK2 mRNA; more ... | CTD | PMID:20230807 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TNK2 mRNA | CTD | PMID:20938992 |
| clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of TNK2 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of TNK2 mRNA | CTD | PMID:17585979 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of TNK2 mRNA | CTD | PMID:18579281 |
| dibutyl phthalate | decreases expression | ISO | RGD:1305957 | 6480464 | Dibutyl Phthalate results in decreased expression of TNK2 mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | increases expression | ISO | RGD:1346409 | 6480464 | Diethylstilbestrol results in increased expression of TNK2 mRNA | CTD | PMID:15766595 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TNK2 mRNA | CTD | PMID:20938992 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TNK2 mRNA | CTD | PMID:20938992 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of TNK2 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of TNK2 mRNA; more ... | CTD | PMID:17585979 |
| phenobarbital | affects methylation | EXP | | 6480464 | Phenobarbital affects the methylation of TNK2 gene | CTD | PMID:19233941 |
| pyrogallol | increases expression | EXP | | 6480464 | Pyrogallol results in increased expression of TNK2 mRNA | CTD | PMID:20362636 |
| resveratrol | increases expression | ISO | RGD:1346409 | 6480464 | resveratrol results in increased expression of TNK2 mRNA | CTD | PMID:12569576 |
| sodium fluoride | decreases expression | EXP | | 6480464 | Sodium Fluoride results in decreased expression of TNK2 mRNA | CTD | PMID:21340527 |
| trans-resveratrol | increases expression | ISO | RGD:1346409 | 6480464 | resveratrol results in increased expression of TNK2 mRNA | CTD | PMID:12569576 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of TNK2 mRNA | CTD | PMID:17963808 |